Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:businessModel |
gptkb:public_company
|
| gptkbp:founded |
2001
|
| gptkbp:headquartersLocation |
gptkb:Tucson,_Arizona,_United_States
|
| gptkbp:industry |
medical devices
|
| gptkbp:market |
global
|
| gptkbp:notableProduct |
gptkb:SynCardia_temporary_Total_Artificial_Heart
|
| gptkbp:parentCompany |
gptkb:Versa_Capital_Management
|
| gptkbp:product |
gptkb:SynCardia_Total_Artificial_Heart
|
| gptkbp:regulates |
FDA approved
CE Mark approved |
| gptkbp:specializesIn |
artificial heart technology
|
| gptkbp:usedFor |
end-stage heart failure
|
| gptkbp:website |
https://www.syncardia.com/
|
| gptkbp:bfsParent |
gptkb:SynCardia_Total_Artificial_Heart
gptkb:SynCardia_temporary_Total_Artificial_Heart |
| gptkbp:bfsLayer |
9
|
| https://www.w3.org/2000/01/rdf-schema#label |
SynCardia Systems, LLC
|